Details of Drug-Metabolizing Enzyme (DME)
| General Information of DME (ID: DME1440) | |||||
|---|---|---|---|---|---|
| DME Name | Unclear metabolic mechanism (DME-unclear), Mediterraneibacter glycyrrhizinilyticus | ||||
| Gene Name | DME-unclear | ||||
| Lineage | Species: Mediterraneibacter glycyrrhizinilyticus (Click to Show/Hide the Complete Species Lineage) | ||||
| Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME | |||||
| Tissue Distribution | Primarily distributed in human gut. | ||||
| Full List of Drug(s) Metabolized by This DME | |||||
|---|---|---|---|---|---|
| Drugs in Phase 3 Clinical Trial | Click to Show/Hide the Full List of Drugs: 1 Drugs | ||||
BRN-0077922 |
Drug Info | Phase 3 | Influenza virus infection | ICD11: 1E30 | [1] |
| References | |||||
|---|---|---|---|---|---|
| 1 | Clostridium glycyrrhizinilyticum sp. nov., a glycyrrhizin-hydrolysing bacterium isolated from human faeces. Microbiol Immunol. 2006;50(7):481-5. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.